Cancer Drug for Alzheimer's Treatment Wilmington NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Adam Pullan Brown
(910) 799-2262
2800 Ashton Dr Ste 200
Wilmington, NC
Specialty
Neurosurgery

Data Provided by:
Thomas Eric Melin, MD
(910) 799-2262
2800 Ashton Dr Ste 200
Wilmington, NC
Specialties
Neurological Surgery, General Surgery
Gender
Male
Education
Medical School: Univ Of Ky Coll Of Med, Lexington Ky 40536
Graduation Year: 1984
Hospital
Hospital: New Hanover Reg Med Ctr, Wilmington, Nc
Group Practice: Coastal Neurological Assoc

Data Provided by:
David Bachman
(910) 341-3383
1202 Medical Center Dr
Wilmington, NC
Specialty
Neurology

Data Provided by:
David Stanley Bachman, MD
(919) 341-3300
1202 Medical Center Dr
Wilmington, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1969

Data Provided by:
Alfred De Maria
(910) 341-3383
1202 Medical Center Dr
Wilmington, NC
Specialty
Neurology

Data Provided by:
Adam Pullan Brown, MD
(910) 799-2262
2800 Ashton Dr Ste 200
Wilmington, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1987

Data Provided by:
Thomas Eric Melin
(910) 799-2262
2800 Ashton Dr
Wilmington, NC
Specialty
Neurosurgery

Data Provided by:
Dr.David Bachman
(910) 341-3383
2131 South 17th Street
Wilmington, NC
Gender
M
Education
Medical School: Johns Hopkins Univ Sch Of Med
Year of Graduation: 1969
Speciality
Neurologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 3, reviews.

Data Provided by:
George John Scontsas
(910) 251-8414
1201 Medical Center Dr
Wilmington, NC
Specialty
Neurology

Data Provided by:
Dr.TIMOTHY OSTER
(910) 343-7597
2131 South 17th Street
Wilmington, NC
Gender
M
Speciality
Neurologist
General Information
Accepting New Patients: Yes
RateMD Rating
4.0, out of 5 based on 1, reviews.

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com